[go: up one dir, main page]

MX2015016931A - Una formulacion de aceite marino que comprende reservatrol o sus derivados para su uso en el tratamiento, retraso y/o prevencion de la enfermedad de alzheimer. - Google Patents

Una formulacion de aceite marino que comprende reservatrol o sus derivados para su uso en el tratamiento, retraso y/o prevencion de la enfermedad de alzheimer.

Info

Publication number
MX2015016931A
MX2015016931A MX2015016931A MX2015016931A MX2015016931A MX 2015016931 A MX2015016931 A MX 2015016931A MX 2015016931 A MX2015016931 A MX 2015016931A MX 2015016931 A MX2015016931 A MX 2015016931A MX 2015016931 A MX2015016931 A MX 2015016931A
Authority
MX
Mexico
Prior art keywords
alzheimer
disease
formulation
prevention
derivatives
Prior art date
Application number
MX2015016931A
Other languages
English (en)
Other versions
MX363853B (es
Inventor
Janne Sande Mathisen
Henrik Mathisen
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52022528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015016931(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Publication of MX2015016931A publication Critical patent/MX2015016931A/es
Publication of MX363853B publication Critical patent/MX363853B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una formulación que comprende de aceite marino fresco en una emulsión de aceite en agua y resveratrol o sus derivados para su uso en el tratamiento, el retraso y/o la prevención de la enfermedad de Alzheimer o los síntomas asociados con la enfermedad de Alzheimer, incluyendo el deterioro cognitivo leve (MCI).
MX2015016931A 2013-06-13 2014-06-13 Una formulación de aceite marino que comprende resveratrol o sus derivados para su uso en el tratamiento, retraso y/o prevención de la enfermedad de alzheimer. MX363853B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361834455P 2013-06-13 2013-06-13
PCT/NO2014/050099 WO2014200356A1 (en) 2013-06-13 2014-06-13 A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease

Publications (2)

Publication Number Publication Date
MX2015016931A true MX2015016931A (es) 2016-04-04
MX363853B MX363853B (es) 2019-04-05

Family

ID=52022528

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016931A MX363853B (es) 2013-06-13 2014-06-13 Una formulación de aceite marino que comprende resveratrol o sus derivados para su uso en el tratamiento, retraso y/o prevención de la enfermedad de alzheimer.

Country Status (14)

Country Link
US (1) US9717704B2 (es)
EP (1) EP3016666B1 (es)
JP (2) JP6648007B2 (es)
KR (1) KR20160018801A (es)
CN (1) CN105283190A (es)
AU (1) AU2014278839B2 (es)
CA (1) CA2914767A1 (es)
DK (1) DK3016666T3 (es)
ES (1) ES2732307T3 (es)
MX (1) MX363853B (es)
PL (1) PL3016666T3 (es)
PT (1) PT3016666T (es)
SI (1) SI3016666T1 (es)
WO (1) WO2014200356A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014254078A1 (en) 2013-04-19 2015-10-15 Bioventures, Llc Combretastatin analogs
CN105283190A (zh) * 2013-06-13 2016-01-27 飞鱼有限公司 包含白藜芦醇或其衍生物的用于治疗、延缓和/或预防阿尔茨海默氏病的海洋油制剂
CN118562610A (zh) 2013-06-24 2024-08-30 威尔逊沃夫制造公司 用于透气性细胞培养过程的封闭系统装置和方法
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
CA2940694A1 (en) 2014-03-31 2015-10-08 Board Of Trustees Of The University Of Arkansas Disubstituted triazole analogs
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
US20200024249A1 (en) * 2017-02-02 2020-01-23 Bioventures, Llc Methods of protecting against neurodegeneration

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US6184248B1 (en) * 1996-09-05 2001-02-06 Robert K. K. Lee Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
NO313076B1 (no) * 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
DK2218342T3 (en) * 2003-05-27 2018-10-22 Dsm Ip Assets Bv New nutraceutical compositions and their use
NO322041B1 (no) 2004-10-22 2006-08-07 Pharmalogica As Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling.
US20060172012A1 (en) * 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
NO323665B1 (no) 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
NO324262B1 (no) * 2005-11-29 2007-09-17 Pharmalogica As Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder.
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
DE202007013532U1 (de) * 2007-09-26 2007-12-13 Orthomol Pharmazeutische Vertriebs Gmbh Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion
NO20081487L (no) * 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
EP2279667A1 (en) * 2009-07-30 2011-02-02 Brudy Technology, S.L. Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid
WO2012025229A1 (en) * 2010-08-27 2012-03-01 Persavita Ltd. Composition and method of manufacture
CA2830476C (en) * 2011-03-18 2019-09-24 Nestec S.A. Compositions and methods useful for ameliorating age related maladies
WO2014000264A1 (en) 2012-06-29 2014-01-03 Qualcomm Incorporated Td-scdma rscp measurement correlation
CN105283190A (zh) * 2013-06-13 2016-01-27 飞鱼有限公司 包含白藜芦醇或其衍生物的用于治疗、延缓和/或预防阿尔茨海默氏病的海洋油制剂

Also Published As

Publication number Publication date
ES2732307T3 (es) 2019-11-21
EP3016666A4 (en) 2017-03-15
CA2914767A1 (en) 2014-12-18
HK1223263A1 (en) 2017-07-28
AU2014278839B2 (en) 2019-06-20
PT3016666T (pt) 2019-07-11
DK3016666T3 (da) 2019-07-01
JP2016523857A (ja) 2016-08-12
WO2014200356A1 (en) 2014-12-18
MX363853B (es) 2019-04-05
JP6648007B2 (ja) 2020-02-14
JP2019081807A (ja) 2019-05-30
PL3016666T3 (pl) 2019-09-30
CN105283190A (zh) 2016-01-27
EP3016666B1 (en) 2019-05-15
US9717704B2 (en) 2017-08-01
US20150031653A1 (en) 2015-01-29
SI3016666T1 (sl) 2019-09-30
KR20160018801A (ko) 2016-02-17
EP3016666A1 (en) 2016-05-11
AU2014278839A1 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
MX2015016931A (es) Una formulacion de aceite marino que comprende reservatrol o sus derivados para su uso en el tratamiento, retraso y/o prevencion de la enfermedad de alzheimer.
DOP2019000180A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CO2017001994A2 (es) Compuestos activos hacia bromodominios
PT4272834T (pt) Uso terapêutico de mitocôndrias e agentes mitocondriais combinados
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
CL2015001756A1 (es) Compuestos derivados de carbamoilpiridona policiclicos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion de vih en un humano que tiene o se encuentra en riesgo de tener la infeccion.
MX2015014713A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cancer.
NI201500140A (es) Compuestos y composiciones terapéuticos
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
MX2015016627A (es) Vacuna para la malaria.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
CL2015003357A1 (es) Derivados de nucleósidos 4'-fluoro-2'-metil sustituidos
CL2015000976A1 (es) Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados.
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
BR112017011168A2 (pt) medicamentos para retardar a doença de parkinson
CL2016001098A1 (es) Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
CL2016002793A1 (es) Composición en forma de emulsión de aceite en agua que comprende semillas molidas de mostaza blanca o amarilla
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
CO2019004131A2 (es) Glicinato de metformina, composiciones farmacéuticas que comprenden la misma, y métodos de uso de la misma
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.
CL2016002792A1 (es) Composición en forma de una emulsión aceite en agua que comprende semilla de mostaza blanca o amarilla molida
AR112291A1 (es) Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico

Legal Events

Date Code Title Description
FG Grant or registration